In November, we released an update to Medable Studio titled Medable AI. This latest update furthers Studio's unique value proposition, offering sponsors and CROs unprecedented control over the study creation and launch process, as well as scalability, speed, and streamlining of operations.  This provides the easiest, fastest path to study launch in the industry to date.

If this already sounds like something you could use, check out a demo or an in-depth look at its feature set here. 

For everyone else, read below to discover what exactly Medable AI has to offer.

‍

A top-10 global pharmaceutical company came to Medable looking to standardize and scale their weight management trials. The trial was driven by a master protocol with multiple sub-studies across 70+ research sites.

The partner was concerned about the participant and site experience, particularly participant enrollment and study startup timelines, as the trial required participants to enroll through the master protocol before enrolling into a sub-study.

Read ahead to see how Medable accomplished this, beat the forecasted FPI date, and more.